Sera Prognostics, Inc.

NASDAQ

Market Cap.

62.03M

Avg. Volume

123.48K

Price

1W %

1M %

3M %

6M %

1Y %

YTD %

--

--

--

--

--

--

--

AI Generated Qualitative Analysis

AI

Your time is precious, so save it. Use AI to get the most important information from the business.

Learn about Sera Prognostics, Inc.

Sera Prognostics, Inc. News

Sera Prognostics, Inc. Quantitative Score

Overall Score

Business

Growth

Unlock

Business

Quality

Unlock

Stock

Value

Unlock

Price

Move

Price

Momentum

Unlock

Price

Stability

Unlock
Website screenshot
HealthcareMedical - Diagnostics & Research
seraprognostics.com

About Sera Prognostics, Inc.

Sera Prognostics, Inc., a women's health diagnostic company, discovers, develops, and commercializes biomarker tests for improving pregnancy outcomes. The company develops PreTRM test, a blood-based biomarker test to predict the risk of spontaneous preterm birth in asymptomatic singleton pregnancies. It is also developing a portfolio of product candidates for various pregnancy-related conditions, including preeclampsia, molecular time-to-birth, gestational diabetes mellitus, fetal growth restriction, stillbirth, and postpartum depression. The company was incorporated in 2008 and is headquartered in Salt Lake City, Utah.

Sera Prognostics, Inc. Earnings & Revenue

What’s This Company Really Worth? Find Out Instantly.

Warren Buffett’s go-to valuation method is Discounted Cash Flow (DCF). Our tool makes it effortless — no spreadsheets, just answers in a few clicks.

Sera Prognostics, Inc. Financials

Table Compare

Compare SERA metrics with:

   

Earnings & Growth

SERA

None

EPS (TTM) YoY Growth

--

--

Revenue (TTM) YoY Growth

--

--

 

Valuation (TTM)

SERA

None

Price/Earnings Ratio

--

--

Price/Sales Ratio

--

--

 

Profitability & Efficiency (TTM)

SERA

None

Net Profit Margin

--

--

Return on Equity

--

--

 

Financial Health (TTM)

SERA

None

Debt/Assets Ratio

--

--

Assets/Liabilities Ratio

--

--

 

Sera Prognostics, Inc. Income

Sera Prognostics, Inc. Balance Sheet

Sera Prognostics, Inc. Cash Flow

Sera Prognostics, Inc. Financials Over Time

Analysts Rating

Strong Buy

Buy

Hold

Sell

Strong Sell

Metrics Scores

MetricsScore
Discounted Cash FlowsStrong Sell
Return on EquityStrong Sell
Return on AssetsStrong Sell
Debt/Equity RatioBuy
Price/Earnings RatioStrong Sell
Price/Book RatioNeutral

Price Targets


Disclaimer: This 3rd party analysis information is for reference only and does not constitute investment advice.

Historical Market Cap

Shares Outstanding

Sera Prognostics, Inc. Executives

NameRole
Ms. Evguenia Lindgardt M.B.A.President, Chief Executive Officer & Director
Dr. Paul Kearney Ph.D.Chief Data Officer
Dr. John J. Boniface Ph.D.Chief Scientific Officer
Mr. Benjamin G. Jackson J.D.General Counsel
Mr. Robert G. HarrisonChief Information Officer
NameRoleGenderDate of BirthPay
Ms. Evguenia Lindgardt M.B.A.President, Chief Executive Officer & DirectorFemale1975693.4K
Dr. Paul Kearney Ph.D.Chief Data Officer1969468.73K
Dr. John J. Boniface Ph.D.Chief Scientific Officer1963431.28K
Mr. Benjamin G. Jackson J.D.General CounselMale1980410.76K
Mr. Robert G. HarrisonChief Information OfficerMale1966384.18K

Sera Prognostics, Inc. Insider Trades

Date8 May
NameMirza Mansoor Raza
RoleDirector
TransactionDisposed
TypeS-Sale
Shares106
Date8 May
NameLindgardt Zhenya
RoleChief Executive Officer
TransactionDisposed
TypeS-Sale
Shares9406
Date8 May
NameKearney Paul
RoleChief Data Officer
TransactionDisposed
TypeS-Sale
Shares7089
Date8 May
NameJackson Benjamin
RoleGeneral Counsel
TransactionDisposed
TypeS-Sale
Shares7084
Date8 May
NameHarrison Robert Gardner
RoleChief Information Officer
TransactionDisposed
TypeS-Sale
Shares6551
DateNameRoleTransactionTypeShares
8 MayMirza Mansoor RazaDirectorDisposedS-Sale106
8 MayLindgardt ZhenyaChief Executive OfficerDisposedS-Sale9406
8 MayKearney PaulChief Data OfficerDisposedS-Sale7089
8 MayJackson BenjaminGeneral CounselDisposedS-Sale7084
8 MayHarrison Robert GardnerChief Information OfficerDisposedS-Sale6551

Discover More

Streamlined Academy

Sera Prognostics, Inc.

NASDAQ

Market Cap.

62.03M

Avg. Volume

123.48K

Price

1W %

1M %

3M %

6M %

1Y %

YTD %

--

--

--

--

--

--

--

Sera Prognostics, Inc. News

Sera Prognostics, Inc. Quantitative Score

Overall Score

Business

Growth

Unlock

Business

Quality

Unlock

Stock

Value

Unlock

Price

Move

Price

Momentum

Unlock

Price

Stability

Unlock

Sera Prognostics, Inc. Earnings & Revenue

Sera Prognostics, Inc. Income

Sera Prognostics, Inc. Balance Sheet

Sera Prognostics, Inc. Cash Flow

Sera Prognostics, Inc. Financials Over Time

Sera Prognostics, Inc. Executives

NameRole
Ms. Evguenia Lindgardt M.B.A.President, Chief Executive Officer & Director
Dr. Paul Kearney Ph.D.Chief Data Officer
Dr. John J. Boniface Ph.D.Chief Scientific Officer
Mr. Benjamin G. Jackson J.D.General Counsel
Mr. Robert G. HarrisonChief Information Officer
NameRoleGenderDate of BirthPay
Ms. Evguenia Lindgardt M.B.A.President, Chief Executive Officer & DirectorFemale1975693.4K
Dr. Paul Kearney Ph.D.Chief Data Officer1969468.73K
Dr. John J. Boniface Ph.D.Chief Scientific Officer1963431.28K
Mr. Benjamin G. Jackson J.D.General CounselMale1980410.76K
Mr. Robert G. HarrisonChief Information OfficerMale1966384.18K

Sera Prognostics, Inc. Insider Trades

Date8 May
NameMirza Mansoor Raza
RoleDirector
TransactionDisposed
TypeS-Sale
Shares106
Date8 May
NameLindgardt Zhenya
RoleChief Executive Officer
TransactionDisposed
TypeS-Sale
Shares9406
Date8 May
NameKearney Paul
RoleChief Data Officer
TransactionDisposed
TypeS-Sale
Shares7089
Date8 May
NameJackson Benjamin
RoleGeneral Counsel
TransactionDisposed
TypeS-Sale
Shares7084
Date8 May
NameHarrison Robert Gardner
RoleChief Information Officer
TransactionDisposed
TypeS-Sale
Shares6551
DateNameRoleTransactionTypeShares
8 MayMirza Mansoor RazaDirectorDisposedS-Sale106
8 MayLindgardt ZhenyaChief Executive OfficerDisposedS-Sale9406
8 MayKearney PaulChief Data OfficerDisposedS-Sale7089
8 MayJackson BenjaminGeneral CounselDisposedS-Sale7084
8 MayHarrison Robert GardnerChief Information OfficerDisposedS-Sale6551

Streamlined Academy

Website screenshot
HealthcareMedical - Diagnostics & Research
seraprognostics.com

About Sera Prognostics, Inc.

Sera Prognostics, Inc., a women's health diagnostic company, discovers, develops, and commercializes biomarker tests for improving pregnancy outcomes. The company develops PreTRM test, a blood-based biomarker test to predict the risk of spontaneous preterm birth in asymptomatic singleton pregnancies. It is also developing a portfolio of product candidates for various pregnancy-related conditions, including preeclampsia, molecular time-to-birth, gestational diabetes mellitus, fetal growth restriction, stillbirth, and postpartum depression. The company was incorporated in 2008 and is headquartered in Salt Lake City, Utah.

AI Generated Qualitative Analysis

AI

Your time is precious, so save it. Use AI to get the most important information from the business.

Learn about Sera Prognostics, Inc.

What’s This Company Really Worth? Find Out Instantly.

Warren Buffett’s go-to valuation method is Discounted Cash Flow (DCF). Our tool makes it effortless — no spreadsheets, just answers in a few clicks.

Sera Prognostics, Inc. Financials

Table Compare

Compare SERA metrics with:

   

Earnings & Growth

SERA

None

EPS (TTM) YoY Growth

--

--

Revenue (TTM) YoY Growth

--

--

 

Valuation (TTM)

SERA

None

Price/Earnings Ratio

--

--

Price/Sales Ratio

--

--

 

Profitability & Efficiency (TTM)

SERA

None

Net Profit Margin

--

--

Return on Equity

--

--

 

Financial Health (TTM)

SERA

None

Debt/Assets Ratio

--

--

Assets/Liabilities Ratio

--

--

 

Analysts Rating

Strong Buy

Buy

Hold

Sell

Strong Sell

Metrics Scores

MetricsScore
Discounted Cash FlowsStrong Sell
Return on EquityStrong Sell
Return on AssetsStrong Sell
Debt/Equity RatioBuy
Price/Earnings RatioStrong Sell
Price/Book RatioNeutral

Price Targets


Disclaimer: This 3rd party analysis information is for reference only and does not constitute investment advice.

Historical Market Cap

Shares Outstanding

Discover More

The Secret to Analyzing Winning Stocks (Step-by-Step Examples Inside)